1. Home
  2. PLAB vs KROS Comparison

PLAB vs KROS Comparison

Compare PLAB & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • KROS
  • Stock Information
  • Founded
  • PLAB 1969
  • KROS 2015
  • Country
  • PLAB United States
  • KROS United States
  • Employees
  • PLAB N/A
  • KROS N/A
  • Industry
  • PLAB Semiconductors
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • KROS Health Care
  • Exchange
  • PLAB Nasdaq
  • KROS Nasdaq
  • Market Cap
  • PLAB 1.6B
  • KROS 1.8B
  • IPO Year
  • PLAB 1987
  • KROS 2020
  • Fundamental
  • Price
  • PLAB $24.00
  • KROS $17.03
  • Analyst Decision
  • PLAB Strong Buy
  • KROS Buy
  • Analyst Count
  • PLAB 1
  • KROS 11
  • Target Price
  • PLAB $35.00
  • KROS $78.33
  • AVG Volume (30 Days)
  • PLAB 661.0K
  • KROS 1.8M
  • Earning Date
  • PLAB 12-11-2024
  • KROS 11-06-2024
  • Dividend Yield
  • PLAB N/A
  • KROS N/A
  • EPS Growth
  • PLAB 2.96
  • KROS N/A
  • EPS
  • PLAB 2.09
  • KROS N/A
  • Revenue
  • PLAB $866,946,000.00
  • KROS $651,000.00
  • Revenue This Year
  • PLAB N/A
  • KROS $224.66
  • Revenue Next Year
  • PLAB $9.01
  • KROS N/A
  • P/E Ratio
  • PLAB $11.50
  • KROS N/A
  • Revenue Growth
  • PLAB N/A
  • KROS 8037.50
  • 52 Week Low
  • PLAB $20.25
  • KROS $15.67
  • 52 Week High
  • PLAB $34.16
  • KROS $73.00
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 45.27
  • KROS 22.60
  • Support Level
  • PLAB $25.55
  • KROS $16.31
  • Resistance Level
  • PLAB $27.08
  • KROS $21.05
  • Average True Range (ATR)
  • PLAB 1.30
  • KROS 3.29
  • MACD
  • PLAB -0.18
  • KROS -4.56
  • Stochastic Oscillator
  • PLAB 7.00
  • KROS 2.40

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: